TOBY's Revolutionary Urine Test Receives FDA Breakthrough Device Designation for Multi-Cancer Detection TOBY, Inc. has achieved FDA Breakthrough Device Designation for its innovative urine-based test aimed at early multi-cancer detection, showcasing significant potential in cancer screening.

TOBY's Revolutionary Urine Test Receives FDA Breakthrough Device Designation for Multi-Cancer Detection #USA #Austin #TOBY #MCED_Test #FDA_Designation

Yenos Analytical Unveils Revolutionary Urine Test for Early Cancer Detection Discover Yenos Analytical's groundbreaking urine test for early detection of multiple cancers, promising 97% accuracy. It's a game-changer in cancer diagnostics!

Yenos Analytical Unveils Revolutionary Urine Test for Early Cancer Detection #United_States #cancer_detection #El_Dorado_Hills #Yenos_Analytical #MCED_Test